MONTPELLIER, France, July 8, 2026 /PRNewswire/ -- Tsingke, a provider of integrated life science research solutions, participated in the Antibody Industrial Symposium (AIS) 2026, one of Europe's leading conferences dedicated to therapeutic antibodies and biotherapeutics. At the event, the...
Hence then, the article about tsingke highlights ai driven cldn18 2 antibody discovery at ais 2026 was published today ( ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.
Read More Details
Finally We wish PressBee provided you with enough information of ( Tsingke Highlights AI-Driven CLDN18.2 Antibody Discovery at AIS 2026 )
Also on site :
- AuraQuantic positioned as a Leader in the SPARK Matrix™: Intelligent Process Orchestration (IPO), 2026 by QKS Group
- Bournemouth vs AC Milan: Kick-Off Time, TV Channels, and Live Streaming
- Payment Processor Nears Buy Point Amid Accelerating Earnings Growth